NDC 71839-122
Pantoprazole sodium 40 mg per 10 mL injection, powder, for solution
On the label: BE Pharmaceuticals Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| MSN Laboratories Private Limited | Rangareddy District, India | Makes it and tests it | Problems found, fixed voluntarilyDec 21, 2023 · 4 inspections |
Recalls
- Sep 5, 2023 · Class II · Be Pharmaceuticals Ag
Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.
Lots: Lots: (a) GSC04002A, GSC04003A, GSC04004A, GSC04006A, Exp Mar-2024; GSC05001A, GSC05006A, GSC05007A, Exp April-2024; GSC10003A, GSC10005A Exp Sep-2024;GSC06004A, GSC06005A, Exp May-2024; GSC07001A, GSC07007A, GSC07008A, GSC07009A, Exp Jun-2024; GSC08001A, Exp Jul-2024; GSC05009A, Exp Apr-2024; …
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Pantoprazole: every company that makes it
- Form
- injection, powder, for solution, intravenous
- Strength
- 40 mg per 10 mL
- Approval
- ANDA ANDA216171
- On the market since
- May 25, 2022
- Package NDCs
71839-122-0171839-122-1071839-122-25- Official label
- DailyMed (National Library of Medicine), updated Mar 7, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?